NanoLogix, Inc. - Product Pipeline Analysis

November 28, 2012
22 Pages - SKU: GBDT4925603


NanoLogix, Inc. (NanoLogix) is a biotechnology company, based in the US. The company provides rapid diagnostics tools for medical, bio defense, environmental, and industrial uses. Its test kits are used in the rapid detection of live cell microorganisms present in infectious and non-infectious human diseases, environment, industrial settings, veterinary medicine and research and testing laboratories. NanoLogix’s rapid diagnostic test kits are simple that detect viable bacteria and other microorganisms. The company’s product portfolio includes BioNanoPore, BioNanoFilter and TSA-EL Petri Plates. Its BioNanoPore product builds on the rapid detection power of its technology to quickly detect and identify live-cell microorganisms in both small and large-volume samples. The company’s TSA-EL Petri Plates consist of a general purpose media that is used for the isolation and cultivation of a variety of fastidious and non-fastidious microorganisms. NanoLogix is headquartered in Hubbard, Ohio, the US.

This report is a source for data, analysis and actionable intelligence on the NanoLogix, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

More Diagnostics Company reports by GlobalData

LBT Innovations Limited (LBT) - Financial and Strategic SWOT Analysis Review by GlobalData
LBT Innovations Limited (LBT) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and ...
InBios International, Inc. - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryInBios International, Inc. (InBios International) is a medical diagnostic company. The company develops, manufactures and markets medical diagnostic tests for the detection of infectious diseases. ...
Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryCalypte Biomedical Corporation (Calypte) is a diagnostic service provider. The company carries out development, manufacturing and marketing of in-vitro testing algorithms for improved diagnosis of ...
BioMedomics, Inc - Product Pipeline Analysis, 2014 Update by GlobalData
SummaryBioMedomics, Inc. (BioMedomics) is a medical diagnostics company. The company conducts research and develops assays and technologies for use in molecular diagnostics. Its diagnostic platform ...
See all reports like this >>



    Online Download  USD 750  
    Site License  USD 1,500  
    Global Site License  USD 2,250  
US: 800.298.5699
Int'l: +1.240.747.3093

Share this report

    Other tasks

    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!